EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The evolution of display technologies for antibody drug discovery

Julian Rojo-Gallegos, Jason Q Tang, Mark Yarmarkovich, Brandon J DeKosky

Trends in Biotechnology · 2026-11 · 44 (11) · 3177-3192

DOI: 10.1016/j.tibtech.2026.04.021 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Biotechnology, 2026-11. Verfasst von Julian Rojo-Gallegos und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA. Hauptthemen laut MEDLINE: Drug Discovery, Antibodies, Cell Surface Display Techniques, Peptide Library. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, Mark Foundation For Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryAntibodiesCell Surface Display TechniquesPeptide LibraryHumansProtein EngineeringDirected Molecular EvolutionAnimalsHigh-Throughput Screening Assays

Stichwörter der Autor:innen

antibody discoverycomputational designdirected evolutiondisplay technologyengineered antibody formatshigh-throughput screening

Substanzen

AntibodiesPeptide Library

Autor:innen und Institutionen

  • The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA, USA.
  • Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA.
  • Perlmutter Cancer Center, New York University Grossman School of Medicine, New York, NY, USA. Electronic address: mark.yarmarkovich@nyulangone.org.
  • The Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA, USA; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA; Koch Institute for Cancer Research, Massachusetts…

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • Mark Foundation For Cancer Research
  • American Cancer Society
  • University of Kansas
  • Bill and Melinda Gates Foundation
  • Massachusetts Institute of Technology
  • National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases

Zitieren

APA

Rojo-Gallegos, J., Tang, J. Q., Yarmarkovich, M., & DeKosky, B. J. (2026). The evolution of display technologies for antibody drug discovery. Trends in Biotechnology, 44(11), 3177-3192. https://doi.org/10.1016/j.tibtech.2026.04.021

Vancouver

Rojo-Gallegos J, Tang JQ, Yarmarkovich M, DeKosky BJ. The evolution of display technologies for antibody drug discovery. Trends in Biotechnology. 2026;44(11):3177-3192. doi:10.1016/j.tibtech.2026.04.021

BibTeX
@article{RojoGallegos2026,
  author = {Rojo-Gallegos, Julian and Tang, Jason Q and Yarmarkovich, Mark and DeKosky, Brandon J},
  title = {The evolution of display technologies for antibody drug discovery},
  journal = {Trends in Biotechnology},
  year = {2026},
  volume = {44},
  number = {11},
  pages = {3177--3192},
  doi = {10.1016/j.tibtech.2026.04.021}
}
Kostenlos starten →